ArticleMedeniyet medical journal2026
Differentiating Pure and Mixed Mucinous Breast Carcinoma Using Multimodality Imaging: A Retrospective Single-Center Study.
Article in Medeniyet medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the efficacy of mammography, ultrasound, and magnetic resonance imaging (MRI) features in differentiating pure from mixed mucinous breast carcinoma and in identifying imaging characteristics specific to each subtype. Methods: This retrospective single-center study included 68 patients diagnosed with mucinous breast carcinoma between 2017 and 2024. The tumors were classified as pure or mixed mucinous breast carcinomas based on histopathological findings. All available mammography, ultrasound, and MRI examinations were evaluated by a radiologist blinded to the histopathological subtypes. The features, such as tumor shape, margin, signal intensity, mammographic density, echogenicity, and calcifications, were assessed to identify distinctive patterns associated with pure and mixed mucinous breast tumors. Results: Among the 68 patients, 31 (45.6%) had pure mucinous tumors, while 37 (54.4%) had mixed tumors. On ultrasound, pure mucinous carcinomas more frequently demonstrated an oval shape and a homogeneous internal echo pattern, whereas mixed tumors more frequently exhibited an irregular shape (p<0.05). Mammography showed that non-circumscribed margins were significantly more common in mixed tumors than in pure tumors (p=0.02). On MRI, pure mucinous carcinomas predominantly exhibited oval or lobulated shapes, whereas mixed tumors more frequently exhibited irregular shapes (p=0.02). Pure tumors also showed higher T2 signal intensity (p=0.02) and significantly higher median apparent diffusion coefficient (ADC) values than mixed tumors (1815 [interquartile range (IQR), 1596-2062.5] vs. 1336.5 [IQR, 904.25-1602.5]×10 Conclusions: A multimodal imaging approach facilitates differentiation between pure and mixed mucinous breast carcinomas. Among the evaluated modalities, MRI provided the greatest discriminatory value, particularly through T2 signal intensity and ADC measurements, and may complement core needle biopsy when tissue sampling is limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.